BALPHARMA.NSBALPHARMA.NSNSE
Loading
SG&A Expenses Over TimeContracting
Percentile Rank53
3Y CAGR-19.3%
5Y CAGR-7.1%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
-19.3%/yr
vs +31.8%/yr prior
5Y CAGR
-7.1%/yr
Recent deceleration
Acceleration
-51.1pp
Decelerating
Percentile
P53
Within normal range
vs 5Y Ago
0.7x
Contraction
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $294.33M | -44.7% |
| 2025 | $532.29M | +140.1% |
| 2024 | $221.69M | -60.5% |
| 2023 | $560.62M | +17.2% |
| 2022 | $478.19M | +12.4% |
| 2021 | $425.59M | +211.9% |
| 2020 | $136.44M | -26.6% |
| 2019 | $185.83M | -0.1% |
| 2018 | $186.07M | -9.1% |
| 2017 | $204.69M | - |